BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10645902)

  • 1. Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro.
    Shetty S; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L148-56. PubMed ID: 10645902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
    Shetty S; Idell S
    Mol Cell Biochem; 1999 Sep; 199(1-2):189-200. PubMed ID: 10544967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
    Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
    Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells.
    Shetty S; Bdeir K; Cines DB; Idell S
    J Biol Chem; 2003 May; 278(20):18124-31. PubMed ID: 12642587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
    Tanabe T
    Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
    Shetty S; Velusamy T; Shetty RS; Marudamuthu AS; Shetty SK; Florova G; Tucker T; Koenig K; Shetty P; Bhandary YP; Idell S
    Am J Respir Cell Mol Biol; 2010 Sep; 43(3):358-67. PubMed ID: 19855086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
    Idell S
    Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
    Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
    Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
    Lund LR
    FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
    Liu G; Shuman MA; Cohen RL
    Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.
    Stefansson S; Kounnas MZ; Henkin J; Mallampalli RK; Chappell DA; Strickland DK; Argraves WS
    J Cell Sci; 1995 Jun; 108 ( Pt 6)():2361-8. PubMed ID: 7673355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
    Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
    Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
    Jakowlew SB; Mariano JM; You L
    Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.
    Shetty S; Padijnayayveetil J; Tucker T; Stankowska D; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L967-75. PubMed ID: 18836029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.
    Sánchez-Tilló E; de Barrios O; Siles L; Amendola PG; Darling DS; Cuatrecasas M; Castells A; Postigo A
    Clin Cancer Res; 2013 Mar; 19(5):1071-82. PubMed ID: 23340304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer.
    Chambers SK; Gertz RE; Ivins CM; Kacinski BM
    Cancer; 1995 Apr; 75(7):1627-33. PubMed ID: 8826920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.